Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial

Hinks TSC., Cureton L., Knight R., Wang A., Cane JL., Barber VS., Black J., Dutton SJ., Melhorn J., Jabeen M., Moss P., Garlapati R., Baron T., Johnson G., Cantle F., Clarke D., Elkhodair S., Underwood J., Lasserson D., Pavord ID., Morgan S., Richards D.

DOI

10.1016/s2213-2600(21)00263-0

Type

Journal article

Publisher

Elsevier BV

Publication Date

2021-10-01T00:00:00+00:00

Volume

9

Pages

1130 - 1140

Total pages

10

Permalink More information Close